報價延遲最少15分鐘:2025/05/13 12:27 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.585 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.19/-0.46
|
|
企業價值
23.05M
|
| 資產負債 |
|
每股賬面淨值
0.34
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
509.59K
|
|
每股收益
0.05
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/13 12:27 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. |